Breaking Supreme Court Won’t Reconsider Birthright Citizenship Ruling After Deadline Passes Senate Advances Sanctions Bill Against Russia Following Zelenskyy’s Appeal US Missile Interceptor Stockpiles Significantly Depleted Amidst Iran Conflict, Analysis Shows Former Citigroup Executive Sentenced to 30 Years for Sex Crimes Denzel Ward Signs Extension, Becomes Highest-Paid Defensive Back in NFL

Tuesday July 28, 2026

Reporter

Alpha Tau Medical Ltd.

2Articles Published

4Communities Covered

Published Articles

Press Release

Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study’s Pre-Specified Threshold for Success

Jul 21

Press Release

Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center

Jul 15